Standard
The incretin enhancer vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed -cell function in patients with type 2 diabetes. / Mari, A.; Sallas, W.M.; He, Y.L.; Watson, C.; Ligueros-Saylan, M.; Dunning, B.E.; Deacon, Carolyn F.; Holst, Jens Juul; Foley, J.E.
In:
Journal of Clinical Endocrinology and Metabolism, No. 90, 2005, p. 4888-4894.
Research output: Contribution to journal › Journal article › Research
Harvard
Mari, A, Sallas, WM, He, YL, Watson, C, Ligueros-Saylan, M, Dunning, BE, Deacon, CF, Holst, JJ & Foley, JE 2005, 'The incretin enhancer vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed -cell function in patients with type 2 diabetes', Journal of Clinical Endocrinology and Metabolism, no. 90, pp. 4888-4894.
APA
Mari, A., Sallas, W. M., He, Y. L., Watson, C., Ligueros-Saylan, M., Dunning, B. E., Deacon, C. F., Holst, J. J., & Foley, J. E. (2005). The incretin enhancer vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed -cell function in patients with type 2 diabetes. Journal of Clinical Endocrinology and Metabolism, (90), 4888-4894.
Vancouver
Mari A, Sallas WM, He YL, Watson C, Ligueros-Saylan M, Dunning BE et al. The incretin enhancer vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed -cell function in patients with type 2 diabetes. Journal of Clinical Endocrinology and Metabolism. 2005;(90):4888-4894.
Author
Mari, A. ; Sallas, W.M. ; He, Y.L. ; Watson, C. ; Ligueros-Saylan, M. ; Dunning, B.E. ; Deacon, Carolyn F. ; Holst, Jens Juul ; Foley, J.E. / The incretin enhancer vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed -cell function in patients with type 2 diabetes. In: Journal of Clinical Endocrinology and Metabolism. 2005 ; No. 90. pp. 4888-4894.
Bibtex
@article{336de88074c211dbbee902004c4f4f50,
title = "The incretin enhancer vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed -cell function in patients with type 2 diabetes",
author = "A. Mari and W.M. Sallas and Y.L. He and C. Watson and M. Ligueros-Saylan and B.E. Dunning and Deacon, {Carolyn F.} and Holst, {Jens Juul} and J.E. Foley",
year = "2005",
language = "English",
pages = "4888--4894",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "Oxford University Press",
number = "90",
}
RIS
TY - JOUR
T1 - The incretin enhancer vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed -cell function in patients with type 2 diabetes
AU - Mari, A.
AU - Sallas, W.M.
AU - He, Y.L.
AU - Watson, C.
AU - Ligueros-Saylan, M.
AU - Dunning, B.E.
AU - Deacon, Carolyn F.
AU - Holst, Jens Juul
AU - Foley, J.E.
PY - 2005
Y1 - 2005
M3 - Journal article
SP - 4888
EP - 4894
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
SN - 0021-972X
IS - 90
ER -
